CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net revenue	$ 805,858	$ 804,031	$ 2,404,330	$ 2,341,943
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Costs and expenses:
Cost of net revenue	$ 681,866	$ 693,488	$ 2,036,532	$ 2,022,281
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 49,242	$ 45,198	$ 154,632	$ 142,797
Depreciation and amortization, excluding patient equipment depreciation	11,263	14,515	34,023	45,596
Goodwill impairment (note 5)	0	511,866	13,078	511,866
Total costs and expenses	742,371	1,265,067	2,238,265	2,722,540
Operating income (loss)	63,487	(461,036)	166,065	(380,597)
Interest expense, net	31,429	32,306	96,939	96,813
Loss on extinguishment of debt	2,273	0	2,273	0
Change in fair value of warrant liability (note 10)	(2,243)	(9,160)	(1,800)	(31,886)
Other loss, net	0	3,317	3,345	6,574
Income (loss) before income taxes	32,028	(487,499)	65,308	(452,098)
Income tax expense (benefit)	8,073	(34,578)	21,931	(30,893)
Net income (loss)	23,955	(452,921)	43,377	(421,205)
Income attributable to noncontrolling interest	1,096	1,155	3,217	3,187
Net income (loss) attributable to AdaptHealth Corp.	$ 22,859	$ (454,076)	$ 40,160	$ (424,392)
Weighted average common shares outstanding - basic (in shares)	134,303	134,825	133,481	134,549
Weighted average common shares outstanding - diluted (in shares)	136,530	134,982	135,441	135,202
Basic net income (loss) per share (note 11) (in dollars per share)	$ 0.16	$ (3.37)	$ 0.28	$ (3.15)
Diluted net income (loss) per share (note 11) (in dollars per share)	$ 0.15	$ (3.43)	$ 0.27	$ (3.37)